Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells.
about
Therapeutically blocking Interleukin-11 Receptor-α enhances doxorubicin cytotoxicity in high grade type I endometrioid tumours.Development, characterization, and reversal of acquired resistance to the MEK1 inhibitor selumetinib (AZD6244) in an in vivo model of childhood astrocytoma.STAT3 activation in monocytes accelerates liver cancer progression.Image-guided thermal ablation of tumors increases the plasma level of interleukin-6 and interleukin-10.XZH-5 inhibits STAT3 phosphorylation and enhances the cytotoxicity of chemotherapeutic drugs in human breast and pancreatic cancer cells.Transcriptional effects of E3 ligase atrogin-1/MAFbx on apoptosis, hypertrophy and inflammation in neonatal rat cardiomyocytes.Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target.Involvement of interleukin-21 in the regulation of colitis-associated colon cancer.Adipose-derived stem cells promote tumor initiation and accelerate tumor growth by interleukin-6 productionHomoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells.Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic LeukemiaProfound Actions of an Agonist of Growth Hormone-Releasing Hormone on Angiogenic Therapy by Mesenchymal Stem Cells.Quantitative Study of Cell Invasion Process under Extracellular Stimulation of Cytokine in a Microfluidic Device.Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogsAt High Levels, Constitutively Activated STAT3 Induces Apoptosis of Chronic Lymphocytic Leukemia Cells.Increased interleukin-6 expression is associated with poor prognosis and acquired cisplatin resistance in head and neck squamous cell carcinomaSerum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients.Monitoring dendritic cell and cytokine biomarkers during remission prior to relapse in patients with FLT3-ITD acute myeloid leukemia.Gp130-mediated STAT3 activation by S-propargyl-cysteine, an endogenous hydrogen sulfide initiator, prevents doxorubicin-induced cardiotoxicity.Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapyDJ-1 promotes development of DEN-induced hepatocellular carcinoma and proliferation of liver cancer cells.Targeting of the innate immunity/inflammation as complementary anti-tumor therapies.Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment.Inflammation and liver tumorigenesis.Acquisition of radioresistance by IL-6 treatment is caused by suppression of oxidative stress derived from mitochondria after γ-irradiation.Gallic acid against hepatocellular carcinoma: An integrated scheme of the potential mechanisms of action from in vivo study.The Blockade of IL6 Counterparts the Osmolar Stress-Induced Apoptosis in Human Conjunctival Epithelial Cells.Tumor-associated macrophages and anti-tumor therapies: complex links.Recombinant soluble gp130 protein reduces DEN-induced primary hepatocellular carcinoma in mice.Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer.White Adipose Tissue Browning: A Double-edged Sword.Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer.A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells.NFκB and STAT3 synergistically activate the expression of FAT10, a gene counteracting the tumor suppressor p53.Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine.Novel small molecule, XZH-5, inhibits constitutive and interleukin-6-induced STAT3 phosphorylation in human rhabdomyosarcoma cells.XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells.Toll-like receptor 3 (TLR3) protects retinal pigmented epithelium (RPE) cells from oxidative stress through a STAT3-dependent mechanism.Protective effect of suppressing STAT3 activity in LPS-induced acute lung injuryAn in vitro system to characterize prostate cancer progression identified signaling required for self-renewal.
P2860
Q33618450-E0EBE993-0FE6-4D6F-B9B0-44F08E8BBD91Q33861173-BA149087-E65A-486F-91BF-09C67F57315CQ34089708-96086FF0-4CBB-4491-8244-D0A83F52E632Q34205626-5C511061-7745-44A5-8FEC-7346D3D35162Q34441744-83CC023C-FEEA-4A13-AB03-F9F976364897Q34555764-AA413249-05EA-4E2D-9DA1-44685046E979Q34940989-96DAAD3D-1AAA-49D3-945D-378BEEB21227Q35441529-606E12C1-540E-4B23-BD35-AE60E4C4A561Q35781395-B9B470D7-9999-4258-8954-CC7EDAD0BEE0Q35844693-8DDA9742-9AA3-4901-B475-BC1C2CBDC3A6Q36682938-D6BA93FD-B82A-42EA-A6EF-4E9DB0BDB62EQ36730919-BB6355EB-8C42-4705-90CA-A9071D8712C5Q36875903-A7F29A54-5ACB-4CA7-84F7-C67026D4EB1CQ36880907-0CF1DDC1-CCD7-4BBA-A1DC-7B9442614A50Q36906043-4E9C12D3-A68C-4DFC-92C6-35E6342DC3D4Q36908883-60C2548E-56BC-4ADE-8FB8-E3D4C68B4D5CQ36961950-DDE78046-CCBB-40DF-99EB-4300BA35C2C0Q36983304-A93B3907-9956-4248-9B5D-D914ABC6465EQ37412473-EF154BA7-79EC-4E11-A622-880248EB9867Q37702227-7B1B08E3-D2E4-4F7B-8A64-D3A0E13FE3AEQ37702744-CD9F8BC2-DDB1-4A31-9FAF-908A4436AF3DQ37901025-7D19E5CA-91A2-4860-A94F-1DB6D5F81964Q37974937-E37020EA-E994-4FD2-8C92-6EFE49503132Q38107461-DDD52B36-F81D-4242-BD74-217FBF305863Q38716398-4851A14B-076A-4CC7-8522-260B968BEA77Q38723821-B1893BA5-BE12-4CDB-9C64-301B9C7261ABQ38750436-9EA1C0AF-A34D-4A6B-AD85-20DB98F873B9Q38766176-44233449-40F3-4F5C-BD3D-DA462C88A7D8Q38778160-30866916-DAA6-4A24-A9CD-C256C8ECBEA3Q38815951-2D7C6523-E6A2-414C-BBBB-4CBC69DC9ACAQ38891681-A601A5DD-5D9F-4252-8390-EBA7B6A76840Q38939956-5941133D-8FD8-41EA-9BED-77B22C2C6BE3Q38948041-2F37125E-504E-445F-B356-4BC689AE31E4Q39024851-A2BD21A9-916C-4D9C-999F-B34993BA638BQ39293308-0FBD74DE-6F82-4CC2-B899-B09B6EBE9262Q39571277-F4F88286-C5CC-4F52-9612-4C6CE2492E7CQ39594191-336F6A17-171C-41FF-A497-8A922A8BBA23Q40252520-DA79BDDF-FD92-4D1B-9A72-85D445804267Q40471161-8D5AC701-C5DB-4C71-893C-3C8EAD64AAD3Q40888865-2E0736F0-0BFB-43F7-9EC3-CE82F1E5A1BF
P2860
Inhibition of STAT3 signaling blocks the anti-apoptotic activity of IL-6 in human liver cancer cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inhibition of STAT3 signaling ...... 6 in human liver cancer cells.
@ast
Inhibition of STAT3 signaling ...... 6 in human liver cancer cells.
@en
Inhibition of STAT3 signaling ...... 6 in human liver cancer cells.
@nl
type
label
Inhibition of STAT3 signaling ...... 6 in human liver cancer cells.
@ast
Inhibition of STAT3 signaling ...... 6 in human liver cancer cells.
@en
Inhibition of STAT3 signaling ...... 6 in human liver cancer cells.
@nl
prefLabel
Inhibition of STAT3 signaling ...... 6 in human liver cancer cells.
@ast
Inhibition of STAT3 signaling ...... 6 in human liver cancer cells.
@en
Inhibition of STAT3 signaling ...... 6 in human liver cancer cells.
@nl
P2093
P2860
P356
P1476
Inhibition of STAT3 signaling ...... 6 in human liver cancer cells.
@en
P2093
Chenglong Li
Jiayuh Lin
Pui-Kai Li
P2860
P304
27429-27439
P356
10.1074/JBC.M110.142752
P407
P577
2010-06-18T00:00:00Z